THERAVANCE BIOPHARMA INC shareholders Q3 2023

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

THERAVANCE BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 7,012,226$60,515,5108.59%
Irenic Capital Management LP 2,760,948$23,826,9816.76%
Newtyn Management, LLC 1,841,560$15,892,6633.92%
Weiss Asset Management LP 7,457,060$64,354,4283.81%
Park West Asset Management LLC 1,983,251$17,115,4561.57%
Baupost Group 7,419,226$64,0281.23%
Oasis Management Co Ltd. 953,254$8,226,5820.36%
Chescapmanager LLC 287,333$2,479,6840.32%
GSA CAPITAL PARTNERS LLP 325,985$2,8130.24%
Virtus ETF Advisers LLC 29,232$252,2720.15%
PDT Partners, LLC 81,458$702,9830.09%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 227,300$1,961,5990.08%
NJ State Employees Deferred Compensation Plan 58,142$501,7650.08%
OCCUDO QUANTITATIVE STRATEGIES LP 57,417$495,5090.06%
Yakira Capital Management, Inc. 16,898$145,8300.04%
SG Americas Securities, LLC 252,609$2,1800.02%
Leucadia National 302,130$2,607,3820.02%
DARK FOREST CAPITAL MANAGEMENT LP 31,733$273,8560.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 407,525$3,516,9410.02%
Pictet Asset Management Holding SA 2,008,253$17,331,2230.02%
External links

This page lists THERAVANCE BIOPHARMA INC's shareholders in Q3 2023. To view THERAVANCE BIOPHARMA INC's shareholder history, click here.